These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3359430

  • 1. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
    Herman TS, Teicher BA.
    Cancer Res; 1988 May 15; 48(10):2693-7. PubMed ID: 3359430
    [Abstract] [Full Text] [Related]

  • 2. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
    Herman TS, Teicher BA, Holden SA, Pfeffer MR, Jones SM.
    Cancer Res; 1990 May 01; 50(9):2734-40. PubMed ID: 2139359
    [Abstract] [Full Text] [Related]

  • 3. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
    Herman TS, Teicher BA, Pfeffer MR, Khandekar VS, Korbut TT.
    Cancer Res; 1990 Jul 01; 50(13):3826-31. PubMed ID: 2354434
    [Abstract] [Full Text] [Related]

  • 4. Combined modality therapy with bleomycin, hyperthermia, and radiation.
    Teicher BA, Herman TS, Holden SA.
    Cancer Res; 1988 Nov 15; 48(22):6291-7. PubMed ID: 2460220
    [Abstract] [Full Text] [Related]

  • 5. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA, Pfeffer MR, Alvarez Sotomayor E, Herman TS.
    Int J Hyperthermia; 1991 Nov 15; 7(5):773-84. PubMed ID: 1834752
    [Abstract] [Full Text] [Related]

  • 6. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
    Ohno S, Strebel FR, Stephens LC, Siddik ZH, Makino M, Klostergaard J, Tomasovic SP, Khokhar AR, Bull JM.
    Cancer Res; 1992 Aug 01; 52(15):4096-101. PubMed ID: 1638521
    [Abstract] [Full Text] [Related]

  • 7. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A, Rommel F, Breise M, Willers R, Göbel U, Wessalowski R.
    Klin Padiatr; 2002 Aug 01; 214(4):223-9. PubMed ID: 12165906
    [Abstract] [Full Text] [Related]

  • 8. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
    Herman TS, Teicher BA, Coleman CN.
    Cancer Res; 1990 Aug 15; 50(16):5055-9. PubMed ID: 2379171
    [Abstract] [Full Text] [Related]

  • 9. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
    Herman TS, Teicher BA, Chan V, Collins LS, Kaufmann ME, Loh C.
    Cancer Res; 1988 May 01; 48(9):2335-41. PubMed ID: 3356001
    [Abstract] [Full Text] [Related]

  • 10. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
    Overgaard J, Radacic MM, Grau C.
    Cancer Res; 1991 Jan 15; 51(2):707-11. PubMed ID: 1985787
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.
    Ning SC, Hahn GM.
    Cancer Res; 1991 Nov 01; 51(21):5910-4. PubMed ID: 1718588
    [Abstract] [Full Text] [Related]

  • 12. Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma.
    Herman TS, Teicher BA, Holden SA.
    Int J Hyperthermia; 1991 Nov 01; 7(6):893-903. PubMed ID: 1806643
    [Abstract] [Full Text] [Related]

  • 13. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F, Stuart OA, Glehen O, Urano M, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2006 Dec 01; 58(6):719-24. PubMed ID: 16614851
    [Abstract] [Full Text] [Related]

  • 14. Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo.
    Kusumoto T, Holden SA, Ara G, Teicher BA.
    Int J Hyperthermia; 1995 Dec 01; 11(4):575-86. PubMed ID: 7594810
    [Abstract] [Full Text] [Related]

  • 15. Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents.
    Teicher BA, Holden SA, Ara G, Northey D.
    Anticancer Res; 1993 Dec 01; 13(6A):2101-6. PubMed ID: 7507654
    [Abstract] [Full Text] [Related]

  • 16. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin.
    Nishimura Y, Ono K, Hiraoka M, Masunaga S, Jo S, Shibamoto Y, Sasai K, Abe M, Iga K, Ogawa Y.
    Radiat Res; 1990 May 01; 122(2):161-7. PubMed ID: 2336462
    [Abstract] [Full Text] [Related]

  • 17. [Combined effects of gamma rays, cis-diamminedichloroplatinum (CDDP) and systemic hyperthermia mastocytoma transplanted into muscle in the mouse].
    Nakamura W, Komatsu K, Kageyama K.
    C R Seances Soc Biol Fil; 1985 May 01; 179(4):558-62. PubMed ID: 2938683
    [Abstract] [Full Text] [Related]

  • 18. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.
    Baba H, Siddik ZH, Strebel FR, Jenkins GN, Bull JM.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7041-4. PubMed ID: 2582445
    [Abstract] [Full Text] [Related]

  • 19. Combination and individual antitumor effects of hyperthermia, cisplatin, and selected dithiocarbamates.
    Walker EM, Schaefer RF, Henle KJ, Schmidt BJ, Gale GR, Cannon DJ, Jones MM, Moss AJ.
    Ann Clin Lab Sci; 1989 Dec 15; 19(4):242-54. PubMed ID: 2757352
    [Abstract] [Full Text] [Related]

  • 20. Hyperthermic enhancement of cis-diamminedichloroplatinum (II)-induced DNA damage in human esophageal cancer transplantable to nude mice.
    Yano T, Nakatani K, Nakano H, Ihara M, Ohnishi T.
    Anticancer Res; 1993 Dec 15; 13(6A):1989-97. PubMed ID: 8297105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.